Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.350
-0.040 (-2.88%)
At close: Dec 5, 2025, 4:00 PM EST
1.369
+0.019 (1.42%)
After-hours: Dec 5, 2025, 7:59 PM EST
Aptevo Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $11,100 → $5,920 | Strong Buy | Maintains | $11,100 → $5,920 | +438,418.52% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $2,246,640 → $651,200 | Buy | Maintains | $2,246,640 → $651,200 | +48,236,937.04% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $2,083,840 → $1,628,000 | Strong Buy | Maintains | $2,083,840 → $1,628,000 | +120,592,492.59% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,041,920 → $2,246,640 | Buy | Maintains | $1,041,920 → $2,246,640 | +166,417,677.78% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $5,470,080 | Strong Buy | Initiates | $5,470,080 | +405,191,011.11% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $3,190,880 | Buy | Initiates | $3,190,880 | +236,361,381.48% | Sep 9, 2016 |